Manning, Jessica <br/><br/>
Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT interval.  [electronic resource] 

 -  Antimicrobial agents and chemotherapy  Oct 2014 
 - 6056-67 p.  digital 
<br/><br/> Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1098-6596 
<br/><br/><label>Standard No.: </label>10.1128/AAC.02667-14  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antimalarials--administration & dosage<br/>Arrhythmias, Cardiac--chemically induced<br/>Artemisinins--administration & dosage<br/>Double-Blind Method<br/>Female<br/>Humans<br/>Malaria--drug therapy<br/>Male<br/>Quinolines--administration & dosage<br/>Young Adult